-
The pattern of traditional Chinese medicine is regenerated and changed!
Time of Update: 2022-08-15
China Resources' acquisition of Kunpharm not only changed the current pattern of the Chinese medicine industry, but also made it and Sinopharm two major state-owned enterprises further layout in the Chinese medicine sector, but also let the industry see that in the new cycle and new ecology of the development of the pharmaceutical industry, Certainty and potential in the development of the Chinese medicine industry .
-
The 3rd Anniversary of the Science and Technology Innovation Board has outstanding performance in biomedicine!
Time of Update: 2022-08-15
[Pharmaceutical Network Pharmaceutical Stock Market] On July 25, Qiming Venture Capital, an innovative drug research and development enterprise, Yifang Bio, successfully landed on the Science and Technology Innovation Board .
-
The product line is rich, and the home medical device industry is full of vitality
Time of Update: 2022-08-15
Rapid market growth and active domestic brands With the aging of the population, the improvement of testing and diagnosis and treatment technologies, and the development of data collection and chronic disease management services, the global home medical device market has shown a momentum of rapid development .
-
The results of the seventh batch of state-organized centralized drug procurement will be released today!
Time of Update: 2022-08-15
. Huahai Pharmaceutical stated in its announcement on July 8 that Oseltamivir Phosphate Capsules obtained the "Drug Registration Certificate" from the State Food and Drug Administration, marking the company's qualification to sell the drug in the domestic market and further enriching the company's products.
-
The concentration of the pharmacy industry continues to increase, and 70,000 stores will disappear!
Time of Update: 2022-08-15
[Pharmaceutical Network Market Analysis] Compared with developed countries, China's pharmaceutical retail industry market chain rate is still relatively low, with multiple, small and scattered compet
-
Since the beginning of 2022, 24 pharmaceutical stocks have risen by more than 20%
Time of Update: 2022-08-15
The stock is also a stock that has outperformed the broader market in the past month, with a cumulative turnover rate of over 30% in the past 5 days Xinhua Pharma: Range rose over 155% Xinhua Pharma's share price rose over 155% from January 4 to June 22.
-
The traditional Chinese medicine sector rose again today, with multiple stocks up more than 5%
Time of Update: 2022-08-15
. According to the data, Gushengtang is a company that focuses on basic medical care, combines new traditional Chinese medicine with modern medical methods, and creates a technology empowerment for customers that integrates offline business and online layout, covering the whole life cycle and all-scenario health management.
-
Under the tide of acquisitions in the pharmaceutical industry, leading companies are accelerating their integration
Time of Update: 2022-08-15
It is understood that the acquisition will help Chutian Technology to expand its product series; at the same time, it will further strengthen the company's competitiveness in the field of pharmaceutical equipment, and the layout of multiple industrial chains will enhance the ability to resist risks and sustainable development .
-
Traditional Chinese medicine, CRO and other pharmaceutical sub-sectors pulled up, and Xintian Pharmaceuticals rose by the daily limit
Time of Update: 2022-08-15
Its business covers the whole chain of drug R&D and production, including drug discovery, pharmaceutical research, clinical trials, customized R&D and production, and registration application According to the data, Baicheng Pharmaceutical is a comprehensive pharmaceutical R&D enterprise with technology development as the core.
-
This pharmaceutical stock has achieved 4 daily limits in a row, and has 253 subsidiaries by the end of 2021
Time of Update: 2022-08-15
. During the period, the company's performance also experienced rapid growth, but in 2019, Ruikang Pharmaceutical achieved a net profit of -928 million yuan attributable to the parent, a sharp drop of 220.
-
In response to market demand, the pharmaceutical equipment industry presents three major trends
Time of Update: 2022-08-15
The industry as a whole presents three trends of integration, automation and intelligence, and is gradually realizing Import substitution of high-end pharmaceutical equipment In this context, some pharmaceutical equipment companies actively respond to market demand, continuously strengthen independent research and development and technological innovation, and improve the manufacturing level and production capacity of equipment.
-
In July, executives of pharmaceutical companies set off another wave of departures, and the industry environment is changing
Time of Update: 2022-08-15
On July 4, Xinmai Medical announced that the company's board of directors recently received a resignation report from deputy general manager Jin Guocheng .
On July 4, Xinmai Medical announced that the company's board of directors recently received a resignation report from deputy general manager Jin Guocheng .
-
The 450 million yuan antibiotic variety market has added another winner!
Time of Update: 2022-08-15
Generic drug quality and efficacy consistency evaluation [Pharmaceutical Network Market Analysis] On August 4, Yuekang Pharmaceutical issued an announcement saying that the company recently received the "Approval Notice for Supplementary Drug Application" for azithromycin for injection (0.
-
Faced with intensified market competition, pharmaceutical equipment companies are further expanding their product lines
Time of Update: 2022-08-15
( A total of 49% of the shares held by minority shareholders of "Chutian Yunfei") Pharmaceutical equipment companies are further expanding their product lines (Source: Pharmaceutical Network) For example, recently, Truking Technology disclosed a plan for additional asset purchases, and plans to purchase its holding subsidiary, Truking Feiyun Pharmaceutical Equipment (Changsha) Co.
-
The medical sector was active, and many stocks such as Innovative Medical and Ogilvy Medical rose by the daily limit
Time of Update: 2022-08-15
The company started out in the hyaluronic acid business and occupies a dominant position in the domestic sodium hyaluronate medical beauty preparation field Amic is a leading non-surgical medical beauty company.
-
On June 1, many pharmaceutical stocks such as Zejing Pharma hit their daily limit
Time of Update: 2022-08-15
13%; at the same time, the company is in the pre-expansion stage of drug listing and commercialization, and needs to invest a lot of pre-market expansion and academic promotion activities The 2021 annual report shows that Zejing Pharmaceutical will achieve revenue of 190 million yuan in 2021, a year-on-year increase of 588.
-
With the intensification of involution, where is the breakthrough for local pharmaceutical companies to "go overseas"?
Time of Update: 2022-08-15
For example, at the end of February this year, Legend Bio's CAR-T therapy Sidaki Aurexa was successfully approved by the FDA for the treatment of relapsed/refractory multiple Myeloma (r/r MM) patients, this is also the second innovative drug successfully launched in the United States after BeiGene's zanubrutinib In recent years, there have been many cases where local pharmaceutical companies have applied to the FAD for their products.
-
The development of traditional Chinese medicine continues to improve, and the pharmaceutical equipment of traditional Chinese medicine is constantly changing to "intelligent manufacturing"!
Time of Update: 2022-08-15
It will help more and more enterprises to achieve more efficient production With the development and application of new technologies such as the Internet of Everything, big data, and artificial intelligence, the positive shift to "intelligent manufacturing" brings more imagination to the traditional Chinese medicine industry.
-
The subscription of new shares has long been known, and there will be a new pharmaceutical stock next week!
Time of Update: 2022-08-15
Further improve the core competitiveness of enterprises Among them, the new drug research and development project in the fundraising project aims to invest in the research and development of a number of clinical and preclinical products, and provide patients with safe, effective and affordable high-quality drugs through innovative research and development to meet the urgent treatment needs.
-
The pharmaceutical e-commerce sector rose, and many stocks rose more than 9%
Time of Update: 2022-08-15
1 billion yuan, a year-on-year increase of about 26% Entering 2022, relevant data shows that from January to April 2022, the national pharmaceutical e-commerce B2C market size is 44.
